Literature DB >> 19112165

Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor.

Rui Chen1, Xi Chen, Robert G Salomon, Thomas M McIntyre.   

Abstract

OBJECTIVE: Mitochondrial depolarization aids platelet activation. Oxidized LDL (oxLDL) contains the medium length oxidatively truncated phospholipid hexadecyl azelaoyl-lysoPAF (HAz-LPAF) that disrupts mitochondrial function in nucleated cells, so oxLDL may augment platelet activation. METHODS AND
RESULTS: Flow cytometry showed intact oxLDL particles synergized with subthreshold amounts of soluble agonists to increase intracellular Ca2+, and initiate platelet aggregation and surface expression of activated gpIIb/IIIa and P-selectin. oxLDL also induced aggregation and increased intracellular Ca2+ in FURA2-labeled cells by itself at low, although not higher, concentrations. HAz-LPAF, alone and in combination with substimulatory amounts of thrombin, rapidly increased cytoplasmic Ca2+ and initiated aggregation. HAz-LPAF depolarized mitochondria in intact platelets, but this required concentrations beyond those that directly activated platelets. An unexpectedly large series of chemically pure truncated phospholipids generated by oxidative fragmentation of arachidonoyl-, docosahexaneoyl-, or linoleoyl alkyl phospholipids were platelet agonists. The PAF receptor, thought to effectively recognize only phospholipids with very short sn-2 residues, was essential for platelet activation because PAF receptor agonists blocked signaling by all these medium length phospholipids and oxLDL.
CONCLUSIONS: Intact oxLDL particles activate platelets through the PAF receptor, and the PAF receptor responds to a far wider range of oxidized phospholipids in oxLDL than anticipated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112165      PMCID: PMC2652042          DOI: 10.1161/ATVBAHA.108.178731

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  48 in total

Review 1.  The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

Authors:  J L Witztum; D Steinberg
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

Review 2.  Platelet-activating factor receptor.

Authors:  Satoshi Ishii; Takahide Nagase; Takao Shimizu
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

3.  Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.

Authors:  Joakim Huber; Anja Vales; Goran Mitulovic; Michael Blumer; Rainer Schmid; Joseph L Witztum; Bernd R Binder; Norbert Leitinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

Review 4.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 5.  Myeloperoxidase-generated oxidants and atherosclerosis.

Authors:  E A Podrez; H M Abu-Soud; S L Hazen
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

6.  Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets.

Authors:  P Maschberger; M Bauer; J Baumann-Siemons; K J Zangl; E V Negrescu; A J Reininger; W Siess
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

Review 7.  Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury.

Authors:  Albert J Chong; Timothy H Pohlman; Craig R Hampton; Akira Shimamoto; Nigel Mackman; Edward D Verrier
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

8.  Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Bogdan Gugiu; Paul L Fox; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

9.  Polyunsaturated phospholipids promote the oxidation and fragmentation of gamma-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids.

Authors:  Xi Chen; Wujuan Zhang; James Laird; Stanley L Hazen; Robert G Salomon
Journal:  J Lipid Res       Date:  2007-12-29       Impact factor: 5.922

10.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients.

Authors:  Wolfgang Drobnik; Gerhard Liebisch; Franz-Xaver Audebert; Dieter Frohlich; Thomas Gluck; Peter Vogel; Gregor Rothe; Gerd Schmitz
Journal:  J Lipid Res       Date:  2003-01-16       Impact factor: 5.922

View more
  27 in total

1.  Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.

Authors:  Yongxue Yao; Kathleen A Harrison; Mohammed Al-Hassani; Robert C Murphy; Samin Rezania; Raymond L Konger; Jeffrey B Travers
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

Review 2.  Regulation of platelet function by class B scavenger receptors in hyperlipidemia.

Authors:  Alejandro Zimman; Eugene A Podrez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 3.  To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.

Authors:  Gopal Kedihitlu Marathe; Chaitanya Pandit; Chikkamenahalli Lakshminarayana Lakshmikanth; Vyala Hanumanthareddy Chaithra; Shancy Petsel Jacob; Cletus Joseph Michael D'Souza
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

4.  Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2015-05-21       Impact factor: 7.376

Review 5.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation.

Authors:  Thomas M McIntyre
Journal:  Biochim Biophys Acta       Date:  2012-03-16

6.  Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.

Authors:  Vyala Hanumanthareddy Chaithra; Shancy Petsel Jacob; Chikkamenahalli Lakshminarayana Lakshmikanth; Mosale Seetharam Sumanth; Kandahalli Venkataranganayaka Abhilasha; Chu-Huang Chen; Anita Thyagarajan; Ravi P Sahu; Jeffery Bryant Travers; Thomas M McIntyre; Kempaiah Kemparaju; Gopal Kedihithlu Marathe
Journal:  J Lipid Res       Date:  2018-08-23       Impact factor: 5.922

7.  Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2014-01-08       Impact factor: 7.376

Review 8.  Role of phospholipid oxidation products in atherosclerosis.

Authors:  Sangderk Lee; Konstantin G Birukov; Casey E Romanoski; James R Springstead; Aldons J Lusis; Judith A Berliner
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

Review 9.  Structural identification and cardiovascular activities of oxidized phospholipids.

Authors:  Robert G Salomon
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

10.  Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL.

Authors:  Rui Chen; Ariel E Feldstein; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.